Lifevantage Corp (LFVN) 1.11 $LFVN
LifeVantage Multi-dimensional Energy Product AXIO Launches in Japan
GlobeNewswire - Fri Feb 13, 8:15AM CST
LifeVantage Corporation (Nasdaq:LFVN), has launched its multi-dimensional energy product, AXIO into the Japanese market. This expansion is consistent with the company's approach of delivering safe, high quality products that are founded in science and backed by research to its Distributors and Preferred Customers worldwide.
LFVN: 1.11 (-0.02)
Protandim Earns NSF Product Certification
GlobeNewswire - Mon Feb 09, 11:00AM CST
LifeVantage Corporation (Nasdaq:LFVN), announced that its flagship product, Protandim, has earned certification from NSF International. Recognized by regulatory agencies at the local, state, federal and international level, NSF certification demonstrates that a product complies with all standard requirements for safety, quality, and performance. NSF conducts periodic facility audits and product testing to verify that the product continues to comply with the standard. LifeVantage is continuing to work with NSF International to complete certification for its international formula of Protandim, currently sold in Japan.
LFVN: 1.11 (-0.02)
LifeVantage FQ2 results
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 12:14PM CST
LFVN: 1.11 (-0.02)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 11:45AM CST
IMMU: 3.84 (unch), AXGN: 3.45 (+0.02), CLW: 63.20 (-0.74), QKLS: 2.10 (-0.24), EOPN: 8.55 (-0.01), HSNI: 67.32 (+1.52), LQDT: 9.52 (+0.09), EOX: 1.15 (unch), GLUU: 5.12 (+0.14), WSTL: 1.45 (+0.10), LFVN: 1.11 (-0.02), HSP: 87.35 (unch), GENE: 8.04 (+1.90), ADEP: 6.93 (-0.30), EARS: 5.88 (-0.01), IVC: 17.13 (+0.15), QUIK: 2.17 (+0.01), ENRJ: 2.81 (+0.06), FARM: 24.00 (-0.19), OSUR: 8.13 (+0.06)
LifeVantage tanks again after earnings report
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:55AM CST
LFVN: 1.11 (-0.02)
LifeVantage's (LFVN) Management on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 04, 5:37PM CST
LFVN: 1.11 (-0.02)
Lifevantage posts 2Q profit
Automated Insights - Wed Feb 04, 4:03PM CST
SANDY, Utah (AP) _ Lifevantage Corp. (LFVN) on Wednesday reported fiscal second-quarter earnings of $1.5 million.
LFVN: 1.11 (-0.02)
LifeVantage misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 3:09PM CST
LFVN: 1.11 (-0.02)
LifeVantage Announces Second Quarter Fiscal Year 2015 Results
GlobeNewswire - Wed Feb 04, 3:06PM CST
Revenue During First Six Months of Fiscal Year 2015, Excluding Japan, Increased 4.5%
LFVN: 1.11 (-0.02)
LifeVantage CEO Robinson resigns
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 5:45PM CST
LFVN: 1.11 (-0.02)
LifeVantage Corporation Announces Executive Leadership Change
GlobeNewswire - Mon Feb 02, 5:05PM CST
- Independent Director Dave S. Manovich to serve as Executive Vice Chairman -
LFVN: 1.11 (-0.02)
LifeVantage reports February 4
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 9:53AM CST
LFVN: 1.11 (-0.02)
LifeVantage to report FQ2 results on Feb. 4
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 8:20AM CST
LFVN: 1.11 (-0.02)
LifeVantage to Announce Second Quarter Fiscal Year 2015 Results on February 4, 2015
GlobeNewswire - Tue Jan 20, 8:00AM CST
LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2014, after the market closes on Wednesday, February 4, 2015. The Company will hold an investor conference call at 2:30 p.m. Mountain Standard Time (4:30 p.m. Eastern Standard Time) that same day.
LFVN: 1.11 (-0.02)
LifeVantage CSO Presenting at Biochemical Society Keap1/Nrf2 Pathway in Health and Disease Meeting
GlobeNewswire - Thu Jan 08, 11:28AM CST
LifeVantage Corporation (Nasdaq:LFVN), announced that Chief Science Officer Shawn M. Talbott, PhD, is presenting a poster abstract demonstrating a portion of the findings from the research being conducted by LifeVantage in the field of Nrf2, at The Biochemical Society's Focused Meeting entitled 'The Keap1/Nrf2 Pathway in Health and Disease' at Robinson College in Cambridge, UK. Dr. Talbott is presenting about how phytonutrients (plant components such as herbal extracts), found in LifeVantage products, can activate the Nrf2 pathway and improve health and balance metabolism. The Nrf2 pathway is emerging as the body's central regulator of health and protector from various sources of stress.
LFVN: 1.11 (-0.02)
LifeVantage Opens Corporate Office in Hong Kong
GlobeNewswire - Tue Dec 02, 12:01PM CST
LifeVantage Corporation (Nasdaq:LFVN), announced the opening of a brand new, state-of-the-art office facility in the Empress Plaza, Hong Kong. This new facility was designed to provide a central location where Distributors can host business-building meetings and conduct training events. We anticipate the office will also allow for a more expedited process for purchasing and receiving LifeVantage products in the Hong Kong region.
LFVN: 1.11 (-0.02)
LifeVantage President & CEO to Present at WFDSA World Congress
GlobeNewswire - Mon Nov 10, 9:08AM CST
LifeVantage Corporation (Nasdaq:LFVN), announced that Douglas C. Robinson will be presenting at The World Federation of Direct Selling Associations (WFDSA) World Congress in the city of Rio De Janeiro. Mr. Robinson is participating as a member of a three-person panel representing fast growing direct selling companies from different geographical regions and cultures that will present their most successful strategies and results within their respective organizations.
LFVN: 1.11 (-0.02)
LifeVantage's (LFVN) CEO Douglas Robinson on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:27PM CST
LFVN: 1.11 (-0.02)
LifeVantage beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 3:56PM CST
LFVN: 1.11 (-0.02)
LifeVantage Multi-dimensional Energy Product AXIO Launches in Japan
GlobeNewswire - Fri Feb 13, 8:15AM CST
LifeVantage Corporation (Nasdaq:LFVN), has launched its multi-dimensional energy product, AXIO into the Japanese market. This expansion is consistent with the company's approach of delivering safe, high quality products that are founded in science and backed by research to its Distributors and Preferred Customers worldwide.
LFVN: 1.11 (-0.02)
Protandim Earns NSF Product Certification
GlobeNewswire - Mon Feb 09, 11:00AM CST
LifeVantage Corporation (Nasdaq:LFVN), announced that its flagship product, Protandim, has earned certification from NSF International. Recognized by regulatory agencies at the local, state, federal and international level, NSF certification demonstrates that a product complies with all standard requirements for safety, quality, and performance. NSF conducts periodic facility audits and product testing to verify that the product continues to comply with the standard. LifeVantage is continuing to work with NSF International to complete certification for its international formula of Protandim, currently sold in Japan.
LFVN: 1.11 (-0.02)
LifeVantage FQ2 results
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 12:14PM CST
LFVN: 1.11 (-0.02)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 11:45AM CST
IMMU: 3.84 (unch), AXGN: 3.45 (+0.02), CLW: 63.20 (-0.74), QKLS: 2.10 (-0.24), EOPN: 8.55 (-0.01), HSNI: 67.32 (+1.52), LQDT: 9.52 (+0.09), EOX: 1.15 (unch), GLUU: 5.12 (+0.14), WSTL: 1.45 (+0.10), LFVN: 1.11 (-0.02), HSP: 87.35 (unch), GENE: 8.04 (+1.90), ADEP: 6.93 (-0.30), EARS: 5.88 (-0.01), IVC: 17.13 (+0.15), QUIK: 2.17 (+0.01), ENRJ: 2.81 (+0.06), FARM: 24.00 (-0.19), OSUR: 8.13 (+0.06)
LifeVantage tanks again after earnings report
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:55AM CST
LFVN: 1.11 (-0.02)
LifeVantage's (LFVN) Management on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 04, 5:37PM CST
LFVN: 1.11 (-0.02)
Lifevantage posts 2Q profit
Automated Insights - Wed Feb 04, 4:03PM CST
SANDY, Utah (AP) _ Lifevantage Corp. (LFVN) on Wednesday reported fiscal second-quarter earnings of $1.5 million.
LFVN: 1.11 (-0.02)
LifeVantage misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 3:09PM CST
LFVN: 1.11 (-0.02)
LifeVantage Announces Second Quarter Fiscal Year 2015 Results
GlobeNewswire - Wed Feb 04, 3:06PM CST
Revenue During First Six Months of Fiscal Year 2015, Excluding Japan, Increased 4.5%
LFVN: 1.11 (-0.02)
LifeVantage CEO Robinson resigns
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 5:45PM CST
LFVN: 1.11 (-0.02)
LifeVantage Corporation Announces Executive Leadership Change
GlobeNewswire - Mon Feb 02, 5:05PM CST
- Independent Director Dave S. Manovich to serve as Executive Vice Chairman -
LFVN: 1.11 (-0.02)
LifeVantage reports February 4
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 9:53AM CST
LFVN: 1.11 (-0.02)
LifeVantage to report FQ2 results on Feb. 4
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 8:20AM CST
LFVN: 1.11 (-0.02)
LifeVantage to Announce Second Quarter Fiscal Year 2015 Results on February 4, 2015
GlobeNewswire - Tue Jan 20, 8:00AM CST
LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2014, after the market closes on Wednesday, February 4, 2015. The Company will hold an investor conference call at 2:30 p.m. Mountain Standard Time (4:30 p.m. Eastern Standard Time) that same day.
LFVN: 1.11 (-0.02)
LifeVantage CSO Presenting at Biochemical Society Keap1/Nrf2 Pathway in Health and Disease Meeting
GlobeNewswire - Thu Jan 08, 11:28AM CST
LifeVantage Corporation (Nasdaq:LFVN), announced that Chief Science Officer Shawn M. Talbott, PhD, is presenting a poster abstract demonstrating a portion of the findings from the research being conducted by LifeVantage in the field of Nrf2, at The Biochemical Society's Focused Meeting entitled 'The Keap1/Nrf2 Pathway in Health and Disease' at Robinson College in Cambridge, UK. Dr. Talbott is presenting about how phytonutrients (plant components such as herbal extracts), found in LifeVantage products, can activate the Nrf2 pathway and improve health and balance metabolism. The Nrf2 pathway is emerging as the body's central regulator of health and protector from various sources of stress.
LFVN: 1.11 (-0.02)
LifeVantage Opens Corporate Office in Hong Kong
GlobeNewswire - Tue Dec 02, 12:01PM CST
LifeVantage Corporation (Nasdaq:LFVN), announced the opening of a brand new, state-of-the-art office facility in the Empress Plaza, Hong Kong. This new facility was designed to provide a central location where Distributors can host business-building meetings and conduct training events. We anticipate the office will also allow for a more expedited process for purchasing and receiving LifeVantage products in the Hong Kong region.
LFVN: 1.11 (-0.02)
LifeVantage President & CEO to Present at WFDSA World Congress
GlobeNewswire - Mon Nov 10, 9:08AM CST
LifeVantage Corporation (Nasdaq:LFVN), announced that Douglas C. Robinson will be presenting at The World Federation of Direct Selling Associations (WFDSA) World Congress in the city of Rio De Janeiro. Mr. Robinson is participating as a member of a three-person panel representing fast growing direct selling companies from different geographical regions and cultures that will present their most successful strategies and results within their respective organizations.
LFVN: 1.11 (-0.02)
LifeVantage's (LFVN) CEO Douglas Robinson on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:27PM CST
LFVN: 1.11 (-0.02)
LifeVantage beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 3:56PM CST
LFVN: 1.11 (-0.02)
